Throat Cancer Stages, Survival Rates and Treatment.

Medically Reviewed by Dr. Aditya Sarin, MD, DrNB

Head & Neck Oncology · Sir Ganga Ram Hospital, New Delhi

Throat Cancer —
Early Detection
Changes Everything.

A comprehensive guide to understanding throat cancer — its types, symptoms, risk factors, diagnosis, and treatment options — by Dr. Aditya Sarin, Medical Oncologist.

📅 Book an Appointment 📞 +91 93151 25514

Medical Disclaimer

This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of throat cancer is different. Please consult Dr. Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

90%+

Survival rate when
detected at Stage I
or Stage II

Section 02

Types of Throat Cancer

Classified by anatomical location within the throat and voice box.

Pharyngeal Cancer

3 subtypes

Upper

Nasopharyngeal

Originates in the upper part of the throat directly behind the nasal cavity.

Middle

Oropharyngeal

Affects the middle throat, including the tonsils and the base of the tongue. Strongly linked to HPV.

Lower

Hypopharyngeal

Located in the lower throat near the voice box; often diagnosed at a later stage.

Laryngeal Cancer

Develops in the larynx (voice box), which contains the vocal cords. Hoarseness or voice change is often the first noticeable sign. It is classified as supraglottic, glottic, or subglottic based on where within the larynx the tumor arises.

Section 01

What is Throat Cancer?

Throat cancer refers to the abnormal, malignant growth of cells in the throat (pharynx), voice box (larynx), or tonsils. It belongs to the broader category of head and neck cancers and can significantly affect essential functions including speech, swallowing, and breathing if not identified and treated early.

With timely diagnosis and access to a multidisciplinary oncology team, many patients achieve excellent outcomes. Awareness of early warning signs is the single most important step in improving prognosis.

Section 03

Symptoms of Throat Cancer

Early symptoms of throat cancer are often overlooked or attributed to common infections. Seek evaluation if any of the following persist for more than three weeks:

Persistent sore throat or chronic cough

Hoarseness or noticeable changes in voice

Difficulty swallowing (dysphagia)

A lump or persistent swelling in the neck

Ear pain or ringing in the ears (tinnitus)

Unexplained weight loss

Blood in saliva or phlegm

Section 04

Causes & Risk Factors

While the exact cause is not always identifiable, several lifestyle, environmental, and genetic factors are associated with an elevated risk of developing throat cancer:

Tobacco & Alcohol Use

Smoking and excessive alcohol consumption are the most significant and modifiable risk factors for all types of throat cancer.

HPV Infection

Human papillomavirus (HPV) — particularly HPV-16 — is strongly linked to oropharyngeal cancers affecting the tonsils and base of tongue.

Poor Oral Hygiene

Chronic gum disease, persistent dental infections, and poor oral hygiene practices may contribute to an elevated risk.

Carcinogen Exposure

Prolonged occupational exposure to asbestos, industrial chemicals, paint fumes, or chronic air pollution increases risk.

GERD / Acid Reflux

Chronic gastroesophageal reflux disease can repeatedly irritate the throat lining, potentially increasing cancer risk over time.

Family History & Genetics

A personal or family history of head and neck cancers may indicate a genetic predisposition to throat cancer development.

Section 05

Diagnosis of Throat Cancer

Early and accurate diagnosis is critical for determining the most effective treatment strategy. Dr. Aditya Sarin employs a comprehensive diagnostic work-up for all suspected cases:

Physical Examination

Thorough check of the throat, neck, and mouth for lumps, lesions, or swelling.
Laryngoscopy

A flexible or rigid scope with a camera to directly visualise the throat and vocal cords.
Biopsy

A tissue sample is taken from the suspected area and sent for laboratory analysis to confirm malignancy.
Imaging (CT / MRI / PET)

Advanced scans to determine tumor size, depth, and whether cancer has spread to lymph nodes or other structures.
HPV Testing

HPV status is tested in oropharyngeal cancers as it influences prognosis and treatment decisions.

Section 06

Stages of Throat Cancer

Staging describes how far the cancer has spread and directly shapes the treatment approach. Throat cancer is generally staged using the AJCC TNM system, which considers tumour size, lymph node involvement and distant metastasis. Since throat cancer covers several distinct sites, staging details vary slightly by location, but the overall structure is consistent. This staging guidance is current as of 2026.

Stage

What it means

Stage I

A small tumour confined to its site of origin, such as the larynx or a specific part of the pharynx, with no lymph node involvement.

Stage II

A larger tumour still confined to its site of origin, or limited spread to a neighbouring subsite, with no lymph node involvement.

Stage III

The tumour has grown further, or has spread to a single nearby lymph node, without spreading to distant sites.

Stage IV

Locally advanced disease with extensive lymph node involvement, spread to nearby structures, or metastasis to distant organs.

For oropharyngeal cancer specifically, HPV status changes how staging is interpreted, since HPV-positive tumours are generally assigned a lower stage than HPV-negative tumours of a similar size, reflecting their better prognosis.

Source: American Cancer Society, Laryngeal Cancer Stages.

Section 07

Survival Rates by Stage

Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient.

Throat cancer survival rate in the United States

Stage at diagnosis

5-year rate

Localized — confined to the larynx

80%

Regional — spread to nearby structures or lymph nodes

50%

Distant — spread to other organs

36%

All stages combined

57%

Source: American Cancer Society, Survival Rates for Laryngeal and Hypopharyngeal Cancer, based on SEER data for cases diagnosed between 2015 and 2021.

Oropharyngeal cancer, particularly HPV-positive disease, generally carries a more favourable outlook than laryngeal or hypopharyngeal cancer, with 5-year survival often exceeding 70 percent for HPV-positive cases specifically.

Source: American Cancer Society, Survival Rates for Oral Cavity and Oropharyngeal Cancer.

Throat cancer survival rate in India

Nationally representative, stage-wise survival data specific to throat cancer is limited. Published research notes that survival for laryngeal cancer in India is considerably lower than in other parts of Asia, though a precise, current national figure comparable to the SEER data above is not available.

Source: Epidemiological review of laryngeal cancer, an Indian perspective, PMC.

Section 08

Treatment Options

Treatment is tailored to the cancer's type, stage, and location, as well as the patient's overall health. A multidisciplinary team approach — combining surgery, radiation, systemic therapy, and supportive care — delivers the best outcomes:

Surgery

Removal of the tumor and affected tissues; may include partial or total laryngectomy in advanced cases.

Radiation Therapy

High-energy rays precisely targeted to destroy cancer cells while sparing healthy surrounding tissue.

Chemotherapy

Systemic drug treatment to kill or shrink cancer cells, often combined with radiation for enhanced effect.

Targeted Therapy

Precision agents such as cetuximab that target specific molecular pathways driving cancer cell growth.

Immunotherapy

Checkpoint inhibitors that reinstate the immune system's ability to recognise and attack cancer cells.

In cases requiring laryngectomy, voice rehabilitation options — including tracheoesophageal voice prosthesis or electronic larynx — are discussed in detail as part of the treatment plan.

Section 09

Latest Advances in Throat Cancer Treatment

Head and neck cancer treatment has seen its most significant regulatory update in years over the past twelve months. As of 2026, notable developments include the following.

FDA Approval · June 12, 2025

First head and neck cancer approval in six years

On June 12, 2025, the FDA approved pembrolizumab as neoadjuvant treatment, continued as adjuvant treatment with radiotherapy, for adults with resectable, locally advanced head and neck squamous cell carcinoma whose tumours express PD-L1.

This was based on the Phase 3 KEYNOTE-689 trial and was the first new approval for this cancer type in six years.

Source: U.S. Food and Drug Administration — FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, 2025.

FDA Approval · Nasopharyngeal

First immunotherapy approved for nasopharyngeal cancer

The FDA approved toripalimab for nasopharyngeal carcinoma — the first immunotherapy drug specifically approved for this cancer type — giving patients with this pharyngeal subtype a treatment option that did not previously exist.

Source: Head and Neck Cancer Drug Pipeline Insight, 2026.

Whether either of these applies to a given patient depends on tumour subtype, PD-L1 or HPV status, and stage, and should be discussed directly with an oncologist.

Section 10

Life After Throat Cancer Treatment

"Treatment is only part of the journey. Helping patients reclaim their voice, their swallowing, and their quality of life — that is where comprehensive care truly begins."

— Dr. Aditya Sarin, Medical Oncologist

Speech therapy and voice rehabilitation if the larynx is affected or removed.

Nutritional support and dietary modifications to manage swallowing difficulties.

Regular follow-up consultations and imaging to monitor for recurrence.

Emotional and psychological counselling for patients and their families.

Support groups connecting survivors for shared experience and resilience.

Section 11

Frequently Asked Questions about Throat Cancer

How long can symptoms of throat cancer be ignored before seeing a doctor?

Persistent hoarseness, difficulty swallowing, or a neck lump lasting more than three weeks should be evaluated by a doctor. These symptoms are often mistaken for common infections, which is why prompt evaluation matters more than waiting to see if they resolve on their own.

Is throat cancer always linked to smoking?

No. Smoking and alcohol use are the most significant risk factors for most throat cancers, but oropharyngeal cancer is increasingly linked to HPV infection, particularly HPV-16, and can occur in people with no history of tobacco or alcohol use.

What is the difference between throat cancer and voice box cancer?

Voice box cancer, or laryngeal cancer, refers specifically to cancer in the larynx, which contains the vocal cords. Throat cancer is a broader term that also includes cancers of the pharynx, such as the nasopharynx, oropharynx, and hypopharynx.

Does HPV-related throat cancer have a better outlook?

Yes. HPV-positive oropharyngeal cancer generally responds better to treatment and has a more favourable prognosis than HPV-negative throat cancers, which is why HPV testing is now a routine part of diagnosis for oropharyngeal cancer.

Will I lose my voice if I need surgery for throat cancer?

Not always. Many early-stage laryngeal cancers can be treated without removing the larynx. When a total laryngectomy is necessary, voice rehabilitation options such as a tracheoesophageal voice prosthesis or an electronic larynx are available to help restore speech.

Can throat cancer come back after successful treatment?

Yes, recurrence is possible, which is why regular follow-up consultations and imaging are a standard part of care after treatment. Most recurrences are detected during these scheduled follow-ups rather than through new symptoms alone.

Is there a screening test for throat cancer?

There is no routine population-wide screening test for throat cancer, unlike mammography for breast cancer. Diagnosis relies on recognising persistent symptoms early and prompt evaluation through physical examination, laryngoscopy, and biopsy.

What is the best treatment approach for Throat Cancer in Delhi?

Effective throat cancer treatment in Delhi requires a multidisciplinary approach coordinating surgery, radiation, and systemic therapy, including newer immunotherapy options for locally advanced disease. Dr. Aditya Sarin coordinates this kind of multidisciplinary head and neck cancer care at Sir Ganga Ram Hospital, New Delhi.

Section 12 · Why Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Throat Cancer Care?

ESMO Board Certified · Harvard Trained · Sir Ganga Ram Hospital, New Delhi

Expert Head & Neck Oncologists

Specialists with deep expertise in all pharyngeal and laryngeal cancer subtypes and their treatment.

Advanced Diagnostics

High-resolution laryngoscopy, molecular diagnostics, and state-of-the-art imaging for precise staging.

Multidisciplinary Team

Oncologists, surgeons, speech therapists, dietitians, and counsellors coordinating your complete care.

Personalised Treatment

Treatment plans tailored to each patient's cancer subtype, stage, HPV status, and individual needs.

Post-Treatment Rehab

Comprehensive rehabilitation including voice restoration, swallowing therapy, and emotional support.

Mon – Fri (Morning) 10:00 AM – 12:00 PM

Mon – Fri (Evening) 4:00 PM – 6:00 PM

Saturday - Sunday Closed

Early Detection Saves Lives

"Persistent symptoms deserve expert attention — don't wait."

Book an appointment with Dr. Aditya Sarin for a thorough evaluation and a personalised throat cancer treatment plan tailored to your unique needs.

📅 Book Your Appointment

+91 93151 25514 +91 78386 82838 dradityasarin@gmail.com

Throat Cancer —Early DetectionChanges Everything.